Kemp & Company Board to Approve FY26 Results on May 25

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Kemp & Company Board to Approve FY26 Results on May 25
Overview

Kemp & Company Ltd will hold a Board meeting on May 25, 2026, to approve audited financial results for the fiscal year and quarter ending March 31, 2026. The company also announced its trading window for securities will be closed from April 1, 2026, until 48 hours after the results are released.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Kemp & Company Board Meeting Set for May 25 to Approve FY26 Results

Kemp & Company Ltd confirmed its Board meeting is scheduled for May 25, 2026. The primary agenda is to approve the company's audited financial results for the fiscal quarter and full year ended March 31, 2026.

This meeting signals the formal release of Kemp & Company's annual financial performance, offering investors and stakeholders clarity on the company's operational and financial health. Concurrently, the company announced its trading window for securities will be closed from April 1, 2026, reopening 48 hours after the results are declared. This is a standard regulatory step to prevent insider trading. Company insiders are therefore restricted from trading securities during this period.

Kemp & Company operates within the pharmaceutical sector, specializing in manufacturing and marketing pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company competes within the broader Indian pharmaceutical industry, where firms like Sun Pharmaceutical Industries Ltd and Divi's Laboratories Ltd are significant players, representing diverse market segments.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.